Investor Ideas #Potcasts 517, #Cannabis News and #Stocks on the Move; (TSX: $APHA.TO) (Nasdaq: $APHA) (TSXV: $N.V) (TSX: $VLNS.TO) (CSE: $PULL.C)
Delta, Kelowna, BC, January 14, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/011421-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/01141APHA-N-VLNS-PULL.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we will be looking at a few public company announcements.
Aphria Inc. (TSX: APHA) (Nasdaq: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the second quarter and six months ended November 30, 2020. All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.
"We are pleased with our second quarter results which reflect the strength of our diversified global cannabis and consumer packaged goods businesses," said Irwin D. Simon, Chairman and Chief Executive Officer. "Our market leading adult-use cannabis brands and sales remained strong and our international medical cannabis sales are off to a solid start. We also advanced our long-term vision for building a global cannabis life-style consumer packaged foods company positioned for sustainable, profitable growth with the completion of our acquisition of SweetWater late in the second quarter. In addition to advancing our long-term vision and growth objectives, the addition of SweetWater is a cornerstone within our U.S. strategy and a strong complement to our existing Aphria business that we believe will return compelling financial benefits. We already hit the ground running by starting to build upon the strengths of each of our respective complementary cannabis lifestyle brands broadening our consumer reach and enhancing loyalty with existing consumers."
Simon continued, "We remain excited about our recently announced definitive agreement with Tilray to combine to create the largest global cannabis company and are on-track to close the transaction in the second quarter of calendar year 2021. At Aphria, we continue to build on our strong foundation in Canada and internationally to capitalize on growth opportunities utilizing our best-in-class cultivation and manufacturing across a greater distribution footprint and enabling us to connect with an increasing number of consumers and patients with our industry-leading brands and diversified product offerings. Looking forward, we are planning to execute on the significant strategic and financial opportunities provided by the addition of SweetWater and, upon the closing of the Tilray business combination, including our over $100 million anticipated pre-tax synergies, to generate significant value for our stakeholders."
Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF), a leading platform for cannabis products, accessories, and education, announced, subject to Exchange approval, further expansion into the USA via CannMart.com with sales of hemp derived CBD. The Company looks forward to leveraging VendorLink, it's marketplace technology, in collaboration with PeakBirch Logic, Inc.
The Company previously announced subject to Exchange approval, through an appropriate affiliate, the sale of accessories in the USA as permissible under state laws. The announcement of this further expansion in the USA underscores Namaste's intention to increase its total addressable market and exploration into other verticals as regulation evolves and other adjacent complementary market opportunities present themselves. The Company is targeting a go-live date for USA customers at CannMart.com by the end of this fiscal quarter.
"We first announced our 24 month collaboration arrangement with PeakBirch in September, 2020 including the possible development of business in the USA and we are delighted to see the first fruits of that collaboration today," said Meni Morim, CEO of Namaste. "With the changing regulatory landscape improving in the USA, our recent announced proposed entry into the USA through the sale of accessories fulfilled by DankStop, and now this proposed entry into the U.S. hemp derived CBD market, we continue the execution of our strategy to position Namaste as a leading global cannabis company and look forward to building on this positive momentum. This development also further validates our investment in technology, as the proposed expansion will be facilitated via our marketplace technology and we are looking forward to launching more vendors onto the platform."
"We are delighted to collaborate with Namaste and join their VendorLink platform to offer hemp derived CBD in the USA at CannMart.com," said Marc Mulvaney, CEO of PeakBirch. "We see great potential in the marketplace to open up our brands to new customers in the USA."
Mr. Meni Morim, CEO will be presenting at the NobleCon17 investor conference on Wednesday, January 20th at 3:45 p.m. EST, discussing this new opportunity and the Company's USA expansion. The conference this year is virtual, with no cost, obligation or restrictions to attend: www.noblecon17.com.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) announced today that it has become an Associate Corporate Member of Food, Health & Consumer Products of Canada (FHCP), the largest voice of the Canadian food, beverage and consumer products industry representing small independently and privately-owned companies as well as large, global multinationals, all of whom manufacture and distribute safe and high-quality consumer packaged goods (CPG) in Canada.
As the leading voice uniting companies, large and small, that provide access to the food, health, and consumer products that Canadians rely on every day, FHCP works to create a favourable business environment that allows its members to bring innovative products to market, promotes environmental stewardship, and standardizes product labelling so that Canadians have choices and ready access to world-leading safe and high-quality products.
Joining FHCP is a natural progression for Valens in establishing a broader CPG footprint and bringing about efforts to normalize cannabinoid products, which now include various health and wellness formats such as beverages and bath and beauty products, beyond what current consumers expect.
"As the only cannabis company in FHCP, our aim is to build out the category using data-driven consumer insights and respond to consumer needs in medical, recreational as well as health and wellness segments," said Tyler Robson, Chief Executive Officer of The Valens Company. "With Cannabis 2.0 and now Cannabis 3.0 products entering the market, we are working to create space within the CPG category where cannabis is part of the conversation. Consumers are already there, which just makes our membership with the FHCP a natural fit to their work and mission."
The relationship with FHCP will allow Valens the opportunity to create strategic category-building connections with over one hundred of Canada's top CPG companies while allowing the Company to educate FHCP members about the benefits of not only major but also minor, non-intoxicating cannabinoids. As a member, The Valens Company will have opportunities to work with CPG peers and facilitate discussion through seminars, workshops, and presentations. The Company will also rely on its extensive experience in cannabinoid research, product development, and large-scale manufacturing, and work with FHCP to develop consumer and trade insights for companies looking to learn more about the cannabis industry.
"Our mission at FHCP is to create and shape a competitive operating environment that fosters innovation and growth for our members, which includes developing categories such as high-quality cannabinoid-based products," said Michael Graydon, Chief Executive Officer of FHCP. "Valens' membership will serve both to educate our members as well as bring cannabis and cannabis products into the conversation when it comes to things like policy discussions, safety and standards, and we're excited to have them on board."
Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) announced that it has delineated the timetable and milestones for its study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at the Toronto Institute of Pharmaceutical Technology by Dr. Alexander MacGregor, a key scientific advisor to the Company.
The study will focus on formulating, manufacturing and clinical bioavailability testing of rapid onset psilocybin dosage forms that could be used in future efficacy clinical trials by both Pure Extracts and its pharmaceutical customers. Clinical batch manufacturing, packaging and labelling are all included in the study as is conformity testing and stability testing (including both long-term and accelerated). The study will conform to both Canadian Good Manufacturing Practice (“GMP”) and Good Clinical Practice (“GCP”) standards.
The key milestones in the 250-day timeline for the study on psilocybin immediate release tablets and nasal gel include the following:
● Sourcing and procurement of medicinal ingredients, excipients & packaging materials
● Raw Material Testing
● Formulation and Manufacturing Process Development, Stability Testing
● Clinical Batch Manufacturing
● Quality Control Release Testing
● Shipping of Clinical Batches to CRO
Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are excited about the R&D progress we are going to make with TIPT over the next 6 – 8 months while waiting to receive our Dealer’s License from Health Canada. We will be well prepared for our move into the controlled substances world of psychedelics and will have advanced knowledge regarding psilocybin and its associated novel delivery mechanisms.”
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
